$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Nov 28, 2025)
$16.40M
Market Cap
-
P/E Ratio
-1.71
EPS
$10.40
52 Week High
$4.26
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Pulmatrix, Inc. is a clinical-stage biopharmaceutical firm based in Lexington, Massachusetts, specializing in the development of inhaled therapies aimed at treating respiratory diseases and serious conditions with significant unmet medical needs. Leveraging its proprietary inhalation drug delivery technologies, the company is advancing a robust pipeline of innovative treatments designed to improve patient outcomes and enhance quality of life. With a strategic commitment to key therapeutic areas, Pulmatrix is well-positioned to be a crucial contributor in the dynamic field of respiratory medicine.
LPTX
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
MARA
WULF
NIO
F
MTSR
VALE
SOFI
GOOGL
BTBT
ADTX
DVLT
GRAB
PFE
DNN
IBRX
RIOT
CAN
AG
WBD
APLD
GOOG
IREN
RIG
BAC
AMD
SMR
TMC
CDE
PLTR
ITUB
AGNC
T
AMC
VHAI
NVO
MSTR
NFLX
SAND
MSFT
HBAN
HL
LPTX
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
MARA
WULF
NIO
F
MTSR
VALE
SOFI
GOOGL
BTBT
ADTX
DVLT
GRAB
PFE
DNN
IBRX
RIOT
CAN
AG
WBD
APLD
GOOG
IREN
RIG
BAC
AMD
SMR
TMC
CDE
PLTR
ITUB
AGNC
T
AMC
VHAI
NVO
MSTR
NFLX
SAND
MSFT
HBAN
HL